Primary diagnosis of prostate cancer: potential role of Ga-68-Prostate Specific Membrane Antigen PET/CT
2018-01-01 Lopci, E; Lazzeri, M; Lughezzani, G; Colombo, P; Buffi, N; Castello, A; Lo Iacono, N; Hurle, R; Saita, A; Peschechera, R; Benetti, A; Zandegiacomo, S; Pasini, L; Lista, G; Casale, P; Balzarini, L; Chiti, A; Guazzoni, G
POSITIVE PROSTATE 68GAPSMA-PET/CT CORRELATES WITH DETECTION OF CD45-/PSMA(+) NON-SPERM EPITHELIAL CELLS OBTAINED BY LIQUID BIOPSY OF SEMINAL FLUID IN PATIENTS WITH PROSTATE CANCER (PCA)
2018-01-01 Lazzeri, M; Lopci, E; Lughezzani, G; Casale, P; Hurle, R; Saita, A; Peschechera, R; Benetti, A; Pasini, L; Zandegiacomo, S; Lista, G; Cardone, P; Chiti, A; Guazzoni, G; Colombo, F; Chiereghin, C; Asselta, R; Monterisi, S; Solda, G; Veronesi, G; Duga, S
Ga-68-PSMA PET/CT for primary diagnosis of prostate cancer in men with contraindications to or negative mpMRI
2018-01-01 Lopci, E; Lazzeri, M; Lughezzani, G; Colombo, P; Buffi, N; Hurle, R; Saita, A; Peschechera, R; Benetti, A; Zandegiacomo, S; Pasini, L; Lista, G; Casale, P; Castello, A; Balzarini, L; Chiti, A; Guazzoni, G
Bendamustine in Combination with Gemcitabine and Vinorelbine (BEGEV) Is an Effective Regimen for Heavily Pretreated, Relapsed/Refractory Hodgkin Lymphoma Patients: A Multicenter, Retrospective Real-World Study
2018-01-01 Russo, A; Pulsoni, A; Viviani, S; Ricci, F; Mazza, R; Magagnoli, M; Morello, L; Landi, F; Guidetti, A; Merli, M; Rodari, M; Serrao, A; Annechini, G; Nervini, A; Giordano, L; Castagna, L; Passamonti, F; Chiti, A; Corradini, P; Santoro, A; Carlo-Stella, C
68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY
2018-01-01 Lazzeri, M; Lopci, E; Lughezzani, G; Buffi, N; Casale, P; Hurle, R; Saita, A; Peschechera, R; Benetti, A; Pasini, L; Zandegiacomo, S; Lista, G; Cardone, P; Chiti, A; Guazzoni, G
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer
2018-01-01 Kirienko, M; Sollini, M; Silvestri, G; Mognetti, S; Voulaz, E; Antunovic, L; Rossi, A; Antiga, L; Chiti, A
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT
2019-01-01 Cozzi, L; Comito, T; Fogliata, A; Franzese, C; Franceschini, D; Bonifacio, C; Tozzi, A; Di Brina, L; Clerici, E; Tomatis, S; Reggiori, G; Lobefalo, F; Stravato, A; Mancosu, P; Zerbi, A; Sollini, M; Margarita, K; Chiti, A; Scorsetti, M
arallel comparison of 68Ga-Prostate Specific Membrane Antigen PET-CT and PRIMUS in primary prostate cancer diagnosis
2019-01-01 Lopci, E; Lughezzani, G; Castello, A; Saita, A; Colombo, P; Buffi, Nm; Lo Iacono, N; Hurle, R; Marzo, K; Leonardi, L; Peschechera, R; Benetti, A; Zandegiacomo, S; Pasini, L; Casale, P; Diana, P; Bevilacqua, G; Mazziotti, E; Balzarini, L; Chiti, A; Guazzoni, G; Lazzeri, M
HCC Radioembolization with Yttrium-90 Polymer Beads (SIR-Spheres):Tc-99m-MAA SPECT/CT based dosimetry correlation with survival and tumor response
2019-01-01 Rodari, M; Tosi, G; Pedicini, V; Poretti, D; Lanza, E; Muglia, R; Marzo, K; Sollini, M; Chiti, A
Value of FDG-PET/CT radiomic features in predicting response to anti-programmed death 1 (PD-1) antibodies treatment in refractory Hodgkin Lymphoma patients
2019-01-01 Sollini, M; Kirienko, M; Cozzi, L; Torrisi, C; Antunovic, L; Tabacchi, E; Calderoni, L; Nanni, C; Alessi, A; Seregni, E; Fanti, S; Guidetti, A; Ricci, F; Corradini, P; Zinzani, P; Stella, Cc; Chiti, A
Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery
2019-01-01 Kirienko, M; Cozzi, L; Antunovic, L; Voulaz, E; Chiti, A; Sollini, M
Prospective evaluation of Ga-68-PSMA PET/CT in primary prostate cancer diagnosis - final results of a dedicated trial
2019-01-01 Lopci, E; Lughezzani, G; Castello, A; Saita, A; Colombo, P; Buffi, N; Lo Iacono, N; Hurle, R; Marzo, K; Leonardi, L; Peschechera, R; Benetti, A; Zandegiacomo, S; Pasini, L; Casale, P; Diana, P; Bevilacqua, G; Mazziotti, E; Balzarini, L; Chiti, A; Guazzoni, G; Lazzeri, M
Baseline Radiomic CT Features Differentiate Mediastinal Masses As Thymic Neoplasms Or Lymphomas
2019-01-01 Ninatti, G; Kirienko, M; Cozzi, L; Voulaz, E; Ricci, F; Carlo-Stella, C; Zucali, P; Chiti, A; Sollini, M
PSMA expression a promising biomarker to predictdifferentiated thyroid cancer aggressiveness and outcome
2019-01-01 Sollini, M; Di Tommaso, L; Kirienko, M; Piombo, C; Erreni, M; Lania, Ag; Antunovic, L; Chiti, A
POTENTIALS OF 68GA-PROSTATE SPECIFIC MEMBRANE ANTIGEN PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER
2019-01-01 Lopci, E; Saita, A; Lughezzani, G; Castello, A; Colombo, P; Buffi, N; Hurle, R; Marzo, K; Leonardi, L; Benetti, A; Casale, P; Fasulo, V; Paciotti, M; Maffei, D; Domanico, L; Bevilacqua, G; Chiti, A; Balzarini, L; Guazzoni, G; Lazzeri, M
EANM/EARL FDG-PET/CT accreditation - summary results from the first 150 accredited imaging sites
2017-01-01 Kaalep, A; Sera, T; Oyen, W; Krause, Bj; Chiti, A; Liu, Y; Boellaard, R
F-18-FDG-PET (PET) and contrast-enhanced CT-scan (CT) in the evaluation of liver metastases from colorectal cancer after chemotherapy
2005-01-01 Carnaghi, Cv; Chiti, A; Marzo, K; Rodari, M; Rimassa, L; Tronconi, Mc; Santoro, A
Timing of response evaluation with 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) in malignant pleural mesothelioma (MPM): "Early'' versus "late'' assessment
2006-01-01 Ceresoli, Gl; Zucali, Pa; Rodari, M; De Vincenzo, F; Salamina, S; Campagnoli, E; Garassino, I; Lutman, Rf; Chiti, A; Santoro, A
Usefulness of FDG-PET imaging in HIV infected individuals for visualization and quantification of lymphatic tissue activation
2006-01-01 Orunesu, E; Gori, A; Clerici, M; Pacei, M; Marzo, K; Bechi, G; Cesari, M; Castelletti, E; Lucignani, G; Chiti, A
FDG PET predicts response in mesothelioma patients treated with pemetrexed based chemotherapy
2006-01-01 Chiti, A; Ceresoli, Gl; Rodari, M; Morenghi, E; Lutman, Rf; Tadayyon, S; Ciocia, G; Santoro, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Primary diagnosis of prostate cancer: potential role of Ga-68-Prostate Specific Membrane Antigen PET/CT | 1-gen-2018 | Lopci, E; Lazzeri, M; Lughezzani, G; Colombo, P; Buffi, N; Castello, A; Lo Iacono, N; Hurle, R; Saita, A; Peschechera, R; Benetti, A; Zandegiacomo, S; Pasini, L; Lista, G; Casale, P; Balzarini, L; Chiti, A; Guazzoni, G | |
| POSITIVE PROSTATE 68GAPSMA-PET/CT CORRELATES WITH DETECTION OF CD45-/PSMA(+) NON-SPERM EPITHELIAL CELLS OBTAINED BY LIQUID BIOPSY OF SEMINAL FLUID IN PATIENTS WITH PROSTATE CANCER (PCA) | 1-gen-2018 | Lazzeri, M; Lopci, E; Lughezzani, G; Casale, P; Hurle, R; Saita, A; Peschechera, R; Benetti, A; Pasini, L; Zandegiacomo, S; Lista, G; Cardone, P; Chiti, A; Guazzoni, G; Colombo, F; Chiereghin, C; Asselta, R; Monterisi, S; Solda, G; Veronesi, G; Duga, S | |
| Ga-68-PSMA PET/CT for primary diagnosis of prostate cancer in men with contraindications to or negative mpMRI | 1-gen-2018 | Lopci, E; Lazzeri, M; Lughezzani, G; Colombo, P; Buffi, N; Hurle, R; Saita, A; Peschechera, R; Benetti, A; Zandegiacomo, S; Pasini, L; Lista, G; Casale, P; Castello, A; Balzarini, L; Chiti, A; Guazzoni, G | |
| Bendamustine in Combination with Gemcitabine and Vinorelbine (BEGEV) Is an Effective Regimen for Heavily Pretreated, Relapsed/Refractory Hodgkin Lymphoma Patients: A Multicenter, Retrospective Real-World Study | 1-gen-2018 | Russo, A; Pulsoni, A; Viviani, S; Ricci, F; Mazza, R; Magagnoli, M; Morello, L; Landi, F; Guidetti, A; Merli, M; Rodari, M; Serrao, A; Annechini, G; Nervini, A; Giordano, L; Castagna, L; Passamonti, F; Chiti, A; Corradini, P; Santoro, A; Carlo-Stella, C | |
| 68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY | 1-gen-2018 | Lazzeri, M; Lopci, E; Lughezzani, G; Buffi, N; Casale, P; Hurle, R; Saita, A; Peschechera, R; Benetti, A; Pasini, L; Zandegiacomo, S; Lista, G; Cardone, P; Chiti, A; Guazzoni, G | |
| Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer | 1-gen-2018 | Kirienko, M; Sollini, M; Silvestri, G; Mognetti, S; Voulaz, E; Antunovic, L; Rossi, A; Antiga, L; Chiti, A | |
| Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT | 1-gen-2019 | Cozzi, L; Comito, T; Fogliata, A; Franzese, C; Franceschini, D; Bonifacio, C; Tozzi, A; Di Brina, L; Clerici, E; Tomatis, S; Reggiori, G; Lobefalo, F; Stravato, A; Mancosu, P; Zerbi, A; Sollini, M; Margarita, K; Chiti, A; Scorsetti, M | |
| arallel comparison of 68Ga-Prostate Specific Membrane Antigen PET-CT and PRIMUS in primary prostate cancer diagnosis | 1-gen-2019 | Lopci, E; Lughezzani, G; Castello, A; Saita, A; Colombo, P; Buffi, Nm; Lo Iacono, N; Hurle, R; Marzo, K; Leonardi, L; Peschechera, R; Benetti, A; Zandegiacomo, S; Pasini, L; Casale, P; Diana, P; Bevilacqua, G; Mazziotti, E; Balzarini, L; Chiti, A; Guazzoni, G; Lazzeri, M | |
| HCC Radioembolization with Yttrium-90 Polymer Beads (SIR-Spheres):Tc-99m-MAA SPECT/CT based dosimetry correlation with survival and tumor response | 1-gen-2019 | Rodari, M; Tosi, G; Pedicini, V; Poretti, D; Lanza, E; Muglia, R; Marzo, K; Sollini, M; Chiti, A | |
| Value of FDG-PET/CT radiomic features in predicting response to anti-programmed death 1 (PD-1) antibodies treatment in refractory Hodgkin Lymphoma patients | 1-gen-2019 | Sollini, M; Kirienko, M; Cozzi, L; Torrisi, C; Antunovic, L; Tabacchi, E; Calderoni, L; Nanni, C; Alessi, A; Seregni, E; Fanti, S; Guidetti, A; Ricci, F; Corradini, P; Zinzani, P; Stella, Cc; Chiti, A | |
| Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery | 1-gen-2019 | Kirienko, M; Cozzi, L; Antunovic, L; Voulaz, E; Chiti, A; Sollini, M | |
| Prospective evaluation of Ga-68-PSMA PET/CT in primary prostate cancer diagnosis - final results of a dedicated trial | 1-gen-2019 | Lopci, E; Lughezzani, G; Castello, A; Saita, A; Colombo, P; Buffi, N; Lo Iacono, N; Hurle, R; Marzo, K; Leonardi, L; Peschechera, R; Benetti, A; Zandegiacomo, S; Pasini, L; Casale, P; Diana, P; Bevilacqua, G; Mazziotti, E; Balzarini, L; Chiti, A; Guazzoni, G; Lazzeri, M | |
| Baseline Radiomic CT Features Differentiate Mediastinal Masses As Thymic Neoplasms Or Lymphomas | 1-gen-2019 | Ninatti, G; Kirienko, M; Cozzi, L; Voulaz, E; Ricci, F; Carlo-Stella, C; Zucali, P; Chiti, A; Sollini, M | |
| PSMA expression a promising biomarker to predictdifferentiated thyroid cancer aggressiveness and outcome | 1-gen-2019 | Sollini, M; Di Tommaso, L; Kirienko, M; Piombo, C; Erreni, M; Lania, Ag; Antunovic, L; Chiti, A | |
| POTENTIALS OF 68GA-PROSTATE SPECIFIC MEMBRANE ANTIGEN PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER | 1-gen-2019 | Lopci, E; Saita, A; Lughezzani, G; Castello, A; Colombo, P; Buffi, N; Hurle, R; Marzo, K; Leonardi, L; Benetti, A; Casale, P; Fasulo, V; Paciotti, M; Maffei, D; Domanico, L; Bevilacqua, G; Chiti, A; Balzarini, L; Guazzoni, G; Lazzeri, M | |
| EANM/EARL FDG-PET/CT accreditation - summary results from the first 150 accredited imaging sites | 1-gen-2017 | Kaalep, A; Sera, T; Oyen, W; Krause, Bj; Chiti, A; Liu, Y; Boellaard, R | |
| F-18-FDG-PET (PET) and contrast-enhanced CT-scan (CT) in the evaluation of liver metastases from colorectal cancer after chemotherapy | 1-gen-2005 | Carnaghi, Cv; Chiti, A; Marzo, K; Rodari, M; Rimassa, L; Tronconi, Mc; Santoro, A | |
| Timing of response evaluation with 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) in malignant pleural mesothelioma (MPM): "Early'' versus "late'' assessment | 1-gen-2006 | Ceresoli, Gl; Zucali, Pa; Rodari, M; De Vincenzo, F; Salamina, S; Campagnoli, E; Garassino, I; Lutman, Rf; Chiti, A; Santoro, A | |
| Usefulness of FDG-PET imaging in HIV infected individuals for visualization and quantification of lymphatic tissue activation | 1-gen-2006 | Orunesu, E; Gori, A; Clerici, M; Pacei, M; Marzo, K; Bechi, G; Cesari, M; Castelletti, E; Lucignani, G; Chiti, A | |
| FDG PET predicts response in mesothelioma patients treated with pemetrexed based chemotherapy | 1-gen-2006 | Chiti, A; Ceresoli, Gl; Rodari, M; Morenghi, E; Lutman, Rf; Tadayyon, S; Ciocia, G; Santoro, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 4 Contributo in Atti di Convegno ...3017
Data di pubblicazione
- In corso di stampa1
- 2020 - 2025370
- 2010 - 2019987
- 2000 - 20091246
- 1990 - 1999399
- 1985 - 198914
Editore
- SAGE PUBLICATIONS LTD152
- LIPPINCOTT WILLIAMS & WILKINS85
- WILEY49
- ELSEVIER30
- Edizioni Minerva Medica22
- OXFORD UNIV PRESS18
- ELSEVIER SCIENCE INC15
- CELL PRESS13
- Società Italiana di Igiene, Medic...11
- BMJ PUBLISHING GROUP10
Rivista
- MULTIPLE SCLEROSIS157
- BLOOD77
- NEUROLOGY76
- INVESTIGATIVE OPHTHALMOLOGY & VIS...65
- EUROPEAN JOURNAL OF NEUROLOGY46
- ANNALS OF ONCOLOGY44
- ANNALS OF THE RHEUMATIC DISEASES27
- GASTROENTEROLOGY26
- HAEMATOLOGICA22
- MOLECULAR THERAPY21
Serie
- IFMBE PROCEEDINGS1
- INTERNATIONAL CONFERENCE ON PATTE...1
- PROCEEDINGS INTERNATIONAL SYMPOSI...1
- RADIOTHERAPY AND ONCOLOGY1
Keyword
- FA16
- ICG16
- MRI16
- OCT16
- RTA16
- SLO16
- Systemic Sclerosis14
- rehabilitation7
- ultrasound)7
- Keywords: imaging methods (CT6
Lingua
- eng1256
- ita450
- fre23
- und21
- ger1
- jpn1
- por1
Accesso al fulltext
- no fulltext2961
- reserved34
- open22